Are you looking for a legal paclitaxel (bulk) supplier in India?
Paclitaxel is a prescription anticancer drug used in chemotherapy. Because it is a controlled, high-risk medicine, legitimate “bulk” supply typically happens through licensed pharmaceutical manufacturers, wholesalers, or authorized distributors—not informal trading.
What qualifies as a “real” bulk supplier for paclitaxel in India?
A supplier is more likely to be legitimate if they can provide documentation such as:
- Manufacturer/distributor licensing and business registration in India
- Drug/medical product approvals for the specific grade (API vs finished dosage form)
- Batch/CoA (Certificate of Analysis), specifications, and traceability
- Compliance with GMP (for API) and quality testing (impurities, identity, assay, stability)
- Shipping documentation for regulated pharmaceuticals
If you tell me whether you need paclitaxel API or finished dosage form (and intended end use: research, formulation, or clinical supply), I can narrow what to ask for and what documentation matters most.
How to avoid counterfeit or non-compliant paclitaxel when sourcing from India
Red flags to watch for include:
- “No paperwork” offers or refusal to share CoA/specs
- Prices that are far below market with no explanation
- No clear manufacturer identity (only a middleman)
- Inconsistent labeling, unclear batch numbers, or missing transport/shipping controls
Where to source verified regulatory/patent context (if you’re screening companies)
If you’re researching suppliers tied to branded or originator supply chains, DrugPatentWatch.com is one place to track drug background and related commercial context (useful during vendor qualification) [1].
Quick questions so I can give you the most relevant supplier guidance
1) Do you need paclitaxel API or a finished product?
2) What quantity (grams/kg) and target grade/spec (if any)?
3) What country will you import into?
4) Is this for R&D, manufacturing, or a licensed clinical supply chain?
Reply with those details and I’ll help you identify the right type of supplier and a practical vetting checklist.
Sources:
[1] https://www.drugpatentwatch.com/